Cargando…

Transformative therapy in hypophosphatasia

Detalles Bibliográficos
Autores principales:	Bishop, Nick, Munns, Craig F, Ozono, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893079/ https://www.ncbi.nlm.nih.gov/pubmed/26992417 http://dx.doi.org/10.1136/archdischild-2015-309579

Ejemplares similares

Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives
por: Offiah, Amaka C., et al.
Publicado: (2018)

SUN-529 Burden of Illness in Adults with Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry
por: Kishnani, Priya, et al.
Publicado: (2019)

Clinical Practice Guidelines for Hypophosphatasia*
por: Michigami, Toshimi, et al.
Publicado: (2020)

Growth and disease burden in children with hypophosphatasia
por: Högler, Wolfgang, et al.
Publicado: (2023)

Clinical Characteristics of Perinatal Lethal Hypophosphatasia: A Report of 6 Cases
por: Nakamura-Utsunomiya, Akari, et al.
Publicado: (2010)

Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms
por: Fujisawa, Yasuko, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
por: Neys, Stefan F. H., et al.
Publicado: (2021)

Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP Registry
por: Dahir, Kathryn M., et al.
Publicado: (2022)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

RNAi Therapy for HIV Infection: Principles and Practicalities
por: Bennasser, Yamina, et al.
Publicado: (2012)

Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry
por: Högler, Wolfgang, et al.
Publicado: (2019)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
por: Jones, Ben J., et al.
Publicado: (2015)

Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
por: Shih, Kent, et al.
Publicado: (2014)

Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis
por: Cather, Jennifer C., et al.
Publicado: (2014)

Severe Acute Respiratory Syndrome: Pertinent Clinical Characteristics and Therapy
por: File, Thomas M., et al.
Publicado: (2012)

Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
por: Rook, Morgan E., et al.
Publicado: (2022)

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
por: Strohl, William R., et al.
Publicado: (2022)

Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy
por: Abreu, Maria T, et al.
Publicado: (2022)

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy
por: Shorrock, Hannah K., et al.
Publicado: (2018)

Call for better response evaluation after neoadjuvant therapy in pancreatic cancer
por: Zaharia, Claudia, et al.
Publicado: (2023)

Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy
por: Rivera-Valentin, Rocio K., et al.
Publicado: (2015)

Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier
por: Stanimirovic, Danica B., et al.
Publicado: (2018)

The Role of Interleukin-8 and its Receptors in Inflammatory Lung Disease: Implications for Therapy
por: Pease, James E., et al.
Publicado: (2012)

Hypophosphatasia
por: Mornet, Etienne
Publicado: (2007)

Hypophosphatasia
por: Tournis, Symeon, et al.
Publicado: (2021)

The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study
por: Holmgren, Johanna, et al.
Publicado: (2022)

Systematic review and meta‐analysis: Is there any role for antioxidant therapy for pain in chronic pancreatitis
por: Mohta, Srikant, et al.
Publicado: (2020)

Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability
por: Cozijnsen, M. A., et al.
Publicado: (2017)

Japanese nationwide survey of hypophosphatasia reveals prominent differences in genetic and dental findings between odonto and non-odonto types
por: Okawa, Rena, et al.
Publicado: (2019)

StellaTUM: current consensus and discussion on pancreatic stellate cell research
por: Erkan, Mert, et al.
Publicado: (2011)

The Introduction of Epidemiology in Training Future Doctors: The Oman Experience
por: Saha, Anjali, et al.
Publicado: (1995)

SUN-334 Real-World Clinical Profiles of Adults with Hypophosphatasia (HPP) from the Global HPP Registry
por: Dahir, Kathryn M, et al.
Publicado: (2020)

Trachoma in an Omani Village – A Health Care Study
por: Cole, Anthony F., et al.
Publicado: (1995)

Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis
por: Zeng, Georgia, et al.
Publicado: (2020)

Correlates of dietary behavior in adults: an umbrella review
por: Sleddens, Ester F.C., et al.
Publicado: (2015)

What’s New in Topicals for Atopic Dermatitis?
por: Kleinman, Elana, et al.
Publicado: (2022)

May the Force Be With You: The Light and Dark Sides of the Microbiota–Gut–Brain Axis in Neuropsychiatry
por: Sherwin, Eoin, et al.
Publicado: (2016)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bt802p2513vfdik99dk75lh9fi